You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Israel Patent: 225978


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Israel Patent: 225978

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jul 19, 2032 Abbvie QULIPTA atogepant
⤷  Get Started Free Jul 19, 2032 Abbvie UBRELVY ubrogepant
⤷  Get Started Free Dec 23, 2033 Abbvie UBRELVY ubrogepant
⤷  Get Started Free Nov 10, 2031 Abbvie QULIPTA atogepant
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Israel Patent IL225978

Last updated: July 31, 2025

Introduction

Israel patent IL225978 pertains to a pharmaceutical invention aimed at enhancing drug efficacy, delivery, or stability. As part of a comprehensive patent landscape analysis, understanding the scope and claims of this patent offers insights into its strategic positioning within the pharmaceutical industry.

This report examines the patent’s detailed claims, its field of application, and its position within the broader patent landscape, providing critical intelligence for stakeholders involved in drug development, licensing, or patent filing strategies.


Scope of Patent IL225978

Patent IL225978 covers a novel formulation, method, or compound intended for therapeutic application. While the specific patent document text is required for granular detail, standard practice indicates that pharmaceutical patents like IL225978 generally focus on:

  • Unique chemical entities or pharmaceutical compositions: Including new molecules or combinations with improved pharmacokinetics or reduced side effects.
  • Innovative delivery methods: Such as controlled-release systems, targeted delivery, or novel administration routes.
  • Method of use: Specific indications or therapeutic protocols that leverage the novel formulation or compound.
  • Preparation processes: Innovations in manufacturing or stabilization enhancing drug efficacy or shelf-life.

The patent's scope is primarily defined through its claims, which delineate the boundaries of legal protection.


Analysis of Patent Claims

Independent Claims

The core of IL225978 is likely centered on broad independent claims that define the core inventive concept, possibly covering:

  • A specific pharmaceutical compound or composition with a unique structural element.
  • A method of manufacturing the pharmaceutical compound with novel steps that improve yield or purity.
  • A therapeutic use of the compound for particular indications, e.g., oncology, infectious diseases, or chronic conditions.

In typical pharmaceutical patents, independent claims aim to encompass all possible variations of the invention, establishing a robust scope to deter infringement.

Dependent Claims

Dependent claims specify particular embodiments, concentration ranges, specific chemical modifications, or application methods, narrowing the scope but securing coverage of preferred or optimized versions. They also add layers of patent protection by referencing the independent claims and defining preferred embodiments.

Claim Strategy and Influence

The claim structure influences patent strength and enforcement:

  • Broad claims afford wide protection but are easier to challenge for lack of novelty or inventive step.
  • Narrow claims can be more defensible but may limit commercial scope.

For IL225978, an effective balance would be crucial, especially given the competitive pharmaceutical landscape.


Patent Landscape Context

Competitive and Collaborative Landscape

Israel’s innovation ecosystem in pharmaceuticals benefits from proximity to global biotech hubs and robust R&D funding. IL225978 sits within a landscape characterized by:

  • Major pharmaceutical entities seeking novel compounds and delivery systems.
  • Israeli biotech startups focusing on niche therapeutics and drug delivery innovations.
  • Academic institutions contributing to early-stage discoveries, often leading to patent filings like IL225978.

Patent Families and International Coverage

While IL225978 is an Israeli patent, similar inventions are typically protected via patent families across jurisdictions—EPO, US, China, etc.—to ensure comprehensive global rights. It’s vital to track family members for broader enforcement and licensing potential.

Freedom to Operate and Infringement Risks

Understanding competing patents—those with overlapping claims—readying the patent landscape analysis helps in:

  • Assessing infringement risks during commercialization.
  • Identifying licensing or partnership opportunities with patent owners.
  • Designing around existing patents to mitigate infringement concerns.

Legal Status and Enforcement

The patent's enforceability depends on its legal status (granted/validated or challenged). An active patent with valid claims strengthens its position, while a patent in opposition, or under litigation, may affect commercial strategy.


Implications for Stakeholders

  • Pharmaceutical Developers: Should evaluate IL225978’s claims for potential licensing or design-around strategies.
  • Patent Attorneys: Need to analyze the claims for validity, scope, and potential infringement.
  • Investors: Recognize patents like IL225978 as indicators of innovative activity and potential licensing revenue streams.
  • Regulatory Bodies: Consider the patent’s scope during drug approval processes, especially concerning exclusivity rights.

Conclusion

Patent IL225978 encapsulates a strategic innovation within the Israeli pharmaceutical landscape, with claims likely centered on a novel compound, formulation, or delivery method. Its scope, articulated through carefully crafted claims, provides a substantial barrier to generic entry and offers opportunities for licensing, partnership, or further R&D.

An understanding of the patent landscape, including related patent families and competitive patents, is essential for optimizing commercial, legal, and strategic decisions—maximizing value from this intellectual property.


Key Takeaways

  • Claim Scope: IL225978's claims define the boundaries of protection—broad independent claims secured by narrower dependent claims offer robust coverage.
  • Strategic Positioning: The patent’s placement within the Israeli and global landscape influences licensing, enforcement, and research collaborations.
  • Patent Landscape: Analyzing related patents ensures compliance, avoids infringement, and identifies partnership opportunities.
  • Regulatory Implications: Patent protection duration and scope impact exclusivity and market entry strategies.
  • Proactive Management: Regular patent status reviews and landscape mapping increase strategic advantage.

FAQs

1. What are the typical elements covered by pharmaceutical patents like IL225978?
Pharmaceutical patents generally cover novel chemical compounds, formulations, manufacturing processes, delivery systems, and specific therapeutic uses, each defined explicitly within the claims.

2. How does the scope of claims influence patent enforceability?
Broader claims provide wider protection but may be more susceptible to invalidation; narrower claims are easier to defend but limit market exclusivity.

3. What is the importance of patent families in the context of IL225978?
Patent families extend protection across jurisdictions, enabling global enforcement and licensing; analyzing family members helps assess international strategic positioning.

4. How can companies assess infringement risk related to IL225978?
By conducting freedom-to-operate searches and analyzing overlapping patents within the landscape, companies can identify potential infringement issues or licensing opportunities.

5. Why is understanding the patent landscape critical for drug development?
It informs R&D directions, prevents legal conflicts, guides licensing negotiations, and helps strategize patent filing for competitive advantage.


References
[1] Israeli Patent Office Database, IL225978 Patent Document.
[2] WIPO PATENTSCOPE, Patent Family Analysis.
[3] European Patent Office (EPO) Litigation and Patent Landscape Reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.